Wellesley, MA, United States of America

Ziyang Yu



Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ziyang Yu in Breast Cancer Treatment

Introduction

Ziyang Yu is a notable inventor based in Wellesley, Massachusetts, known for his significant contributions to the field of cancer treatment. With a total of two patents to his name, Yu is at the forefront of research aimed at addressing specific types of breast cancer, particularly androgen receptor-positive (AR+) breast cancer.

Latest Patents

Yu's latest patents focus on advanced methods for treating AR+ breast cancer. His innovative methodologies involve administering an AR agonist, such as selective androgen receptor modulators (SARMs) like RAD140. These treatments are designed to be utilized alone or in combination with various therapeutic agents, including cdk4/6 inhibitors, m-TOR inhibitors, PI3K inhibitors, PARP inhibitors, BCL-2 inhibitors, and MCL-1 inhibitors. This combination approach is aimed at enhancing the effectiveness of cancer treatment regimes for patients suffering from AR+ breast cancer.

Career Highlights

Ziyang Yu is currently affiliated with Ellipses Pharma Limited, where his work focuses on developing groundbreaking cancer therapies. His research is pivotal in exploring the intersection of hormonal therapies and targeted molecular strategies, bringing hope to patients battling advanced forms of breast cancer.

Collaborations

Collaboration plays a critical role in Yu's research endeavors. Noteworthy among his coworkers are Gary Hattersley and Jamal Saeh, whose combined expertise and insights contribute significantly to the innovative solutions being developed at Ellipses Pharma Limited. This collaborative environment fosters creativity and accelerates the discovery of effective treatment modalities.

Conclusion

Ziyang Yu stands out as a promising inventor in the realm of oncology, with a specific focus on AR+ breast cancer therapies. His patents reflect a commitment to advancing medical science and improving patient outcomes through innovative treatment methods. As he continues to collaborate with talented colleagues, his work is likely to yield further breakthroughs in cancer treatment, marking him as a key figure in medical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…